Fred Alger Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-127
Closed -$3.85K 487
2023
Q2
$3.85K Sell
127
-1,350,978
-100% -$43.7M ﹤0.01% 507
2023
Q1
$43.8M Sell
1,351,105
-538,460
-28% -$17M 0.23% 121
2022
Q4
$53.1M Sell
1,889,565
-645,161
-25% -$18.5M 0.29% 103
2022
Q3
$91.1M Buy
2,534,726
+97,417
+4% +$3.43M 0.46% 58
2022
Q2
$74.8M Sell
2,437,309
-91,563
-4% -$2.67M 0.35% 90
2022
Q1
$81.7M Buy
2,528,872
+75,282
+3% +$1.97M 0.26% 114
2021
Q4
$67.9M Buy
2,453,590
+2,138,500
+679% +$61.3M 0.17% 137
2021
Q3
$9.77M Buy
+315,090
New +$7.56M 0.02% 241
2018
Q3
Sell
-18,000
Closed -$379K 553
2018
Q2
$379K Buy
+18,000
New +$341K ﹤0.01% 365
2016
Q4
Sell
-16,000
Closed -$394K 496
2016
Q3
$394K Buy
16,000
+3,000
+23% +$70.1K ﹤0.01% 364
2016
Q2
$250K Buy
+13,000
New +$179K ﹤0.01% 407

Other funds holding EVH

Fred Alger Management's EVH Position: Q3 2023 in Review

Fred Alger Management sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 127 shares — an estimated $3.85K sold.

Fred Alger Management first reported a position in EVH in Q2 2016 and held it in 11 quarters. The position peaked at $91.1M in Q3 2022. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

  • Fred Alger Management reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
  • Fred Alger Management sold 127 Evolent Health shares in Q3 2023, an estimated $3.85K.
  • Fred Alger Management first reported a position in Evolent Health in Q2 2016 and held it in 11 quarters.
  • Fred Alger Management's Evolent Health position peaked at $91.1M in Q3 2022.
  • 203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.